Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117162) titled 'Cannabidiol for Cannabis Use Disorder in People with Opioid Use Disorder on Buprenorphine' on Sept. 7.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Permuted block randomization, fixed Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Investigator Blinded
Primary Sponsor: All India Institute of Medical Sciences
Condition:
Health Condition 1: F122- Cannabis dependence
Health Condition 2: F112- Opioid dependence
Intervention:
Intervention1: Ta...